Sentences with phrase «year funding program»

European Union officials have proposed a $ 73 billion, 7 - year funding program with money for individual grants and promises of less red tape.

Not exact matches

This year Roar raised $ 5 million in funding and is part of the incubator program of LA Libations, a brand funded in part by Coca - Cola.

«We expect the ECB to extend QE again towards the end of next year, ahead of finishing the program in December 2018, paving the way for a rise in interest rates in the first half of 2019,» said Azad Zangana, senior European economist with London - based fund manager Schroders.

Over the years, the Levi Strauss Foundation had funded «worker empowerment» programming in apparel factories.

The study, published by the Environmental Defense Fund's (EDF) Climate Corps program, says that solar and wind jobs have grown at rates of about 20 % annually in recent years, and sustainability now collectively represents four to four and a half million jobs in the U.S., up from 3.4 million in 2011.

Seattle has almost doubled its funding for affordable housing and homeless services programs since 2013 to $ 63 million per year, according to the report in the Seattle Times.

Last year at the Cannes Lions advertising festival, Nadal awarded $ 1 - million startup funding for an advanced program in New York called the Digital Works Institute.

UNB Fredericton remains popular forsome of its more specialized programs, including an MBA in sport and recreationmanagement, and the student investmentfund — a year - long course for second - yearstudents in which they manage a portionof the province's pension fund.

The funding will continue to the end of the calendar year and into next year, but that's about as much money as there is to run those programs.

He has anchored a number of programs for the network through the years, including «Market Wrap,» «Mutual Fund Investor,» «The Money Club» and the very popular «Power Lunch, «which he had co-hosted with Sue Herera.

«Over the past several years, NASA has been funding a group of psychologists to develop a software program astronauts could use, while aboard spacecraft, to help them work through depression and conflicts with their fellow space - goers.

The spending bill appeared to only be waiting for Trump's signature when he tweeted Friday morning that he was «considering a VETO» because the bill does not fully fund a wall on the Mexican border or create a solution for the Deferred Action for Childhood Arrivals program, a program protecting some undocumented immigrants from deportation that Trump chose last year to end.

The traditional SBIC program limps on, and existing participating security funds will continue to make investments for another couple of years.

Congressional aides said that the White House had suggested a three - year extension of the DACA program in exchange for $ 25 billion in funding for the border wall, a proposal Democrats rejected.

Meanwhile, the report points out, federal funding for housing assistance programs has actually declined by 3 percent in the last seven years.

Bibra Lake - based ZBB Energy Corporation will receive $ 3.1 million over two years in project funding from the Department of the Environment and Water Resources Advanced Electricity Storage Technologies program, the company has announced.

Bankwest today launched its new charity, which will raise funds for community initiatives, as well as a scholarship program that aims to better the lives of Western Australians, and has pledged $ 1 million per year to the charity for five years.

As well, they can participate in the Student Investment Fund, where students in the second year of the program help manage a portion of New Brunswick's pension fFund, where students in the second year of the program help manage a portion of New Brunswick's pension fundfund.

In addition to the Shaw partnership and sponsorship from ICUC Moderation Services, Moderation Town (like Ruby Skye P.I.) received funding through the IPF, which launched a program specifically for web series last year.

GDP grew 2.5 % during the first half of the year, and the country's US$ 4.75 - billion program with the International Monetary Fund is winding up.

«If we don't act, in the next five years we'll be saying the same things: that Greece isn't going well, that there are no jobs... that we have a new program by the International Monetary Fund and European Union to support us,» the 25 - year - old said.

Less than a year after their Indiegogo campaign, Whirlscape has also nabbed $ 500,000 in seed funding from BDC Venture Capital (a Canadian venture capital fund), a U.S. - based fund, and California's renowned Y Combinator incubator, which took Whirlscape on as a participant in its accelerator program earlier this year.

Verizon (vz) says it didn't know about Lanham's fraud and notified an FCC program administrator more than 10 years ago that it had received some E-rate funding in error.

NextGen Climate, which has a well - funded super PAC dedicated to electing lawmakers dedicated to halting climate change, launched a «text - banking» voter - turnout program late last year that attempted to motivate potential voters to show up to vote by sending personalized texts from actual organizers encouraging recipients to respond and start a dialogue.

Every year, admissions officials from top MBA programs across the country gather in a St. Louis hotel to dole out millions in funds from the single largest MBA scholarship fund in the world.

In addition to the fund, Stanford provided a $ 3.6 million grant to the accelerator program to be doled out over three years.

The program works like this: for the first year, seven Ontario scientists have been given $ 50,000 each in one - time funding, plus dedicated business and management training in areas like patent registration, marketing and investment.

The Washington Post reports that the Afghanistan Peace and Reintegration Program, a six - year - old effort that the U.S. and other countries have funded with about $ 200 million, has been suspended while officials reexamine its goals.

This year's appropriations bill, which was signed March 11 and will fund government activities for the year, killed the Bush administration's frequently criticized implementation of the congressionally - mandated program.

Last year, the program funded almost 66,000 jobs, but fell short of the 77,000 positions the Liberals had hoped to fill with the help of an extra $ 113 million annually last year, this year, and next.

The key numbers to focus on here are cash - flow oriented: various expenses (program services, general administrative overhead, and fund - raising), as well as beginning - and end - of - year fund balances.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

«By providing three years advance notice of the move and by funding education and retraining programs for up to four years after the move is complete, we are providing employees with both time and opportunity to help them to make a smooth transition,» the company said.

He criticized states for kicking the can down the road, living beyond their means year after year in a «never - ending sense of crisis» that results in «stop - and - go funding of vital programs,» such as those for infrastructure, education, pensions and city and county services.

HealthIM won $ 25,000 in funding last fall from the University of Waterloo's Velocity accelerator hub and a further $ 60,000 from the school's AC JumpStart program earlier this year.

Infiniti Lab, the luxury brand's startup accelerator program, will return to Toronto for the second consecutive year, giving tech businesses a chance to vie for funding and potential partnerships with the automaker.Thursday, April 26, 11:50 am ET

Since launching our accelerator programs two years ago, 114 startups have graduated, and nearly all that sought a subsequent round of funding received it.

In its early years, a number of her students in the program were teenagers who had come to the country, unauthorized, at a young age and finished high school, but then could not obtain citizenship or receive any state or federal funds for college.

Passionate about the University of Calgary, Schmidt and Laricina Energy Ltd. both played pivotal roles in the Engineering Leaders Campaign at the Schulich School of Engineering, funding a five - year scholarship program, a chemical and petroleum engineering graduate student space, a boardroom in the new engineering building expansion, and a portion of the Canada Research Chair in Energy and Imaging.

Harper did not announce any more money for the Conservative's federal renewable energy program, which runs out of funding this year.

2034 is the year in which Social Security program officials expect the trust funds to run out of money.

The Social Security trust fund ended 2016 with $ 2.85 billion in reserves, and the program is expected to run a modest surplus in every year through 2022.

These include: C$ 4.5 billion to support research, training, and infrastructure at universities and colleges; a Strategic Innovation Fund that will provide C$ 1.26 billion for business innovation in the aerospace and automotive sector; a Connect to Innovate Program that will invest C$ 500 million to bring high - speed Internet to remote and rural communities by 2021; and, C$ 70 million over six years to support agriculture innovation with a focus on climate change, and soil and water conservation.

This budget makes a substantial investment in upgrading away from diesel: $ 220 million (over 11 years) for communities south of the 60th parallel and $ 21.4 million (over four years, starting next year) for continuing an existing northern program, and a portion of a new $ 75 million «challenge» fund aimed at solving clean tech problems through innovation.

The «under» spending or lapse for 2010 - 11 and 2011 - 12 was usually large given that the funds earmarked for the various stimulus programs under the Economic Action Plan were not all required in that year.

Almost this exact time last year, the City ended it's decade - long red light camera program which funded things like the crossing guards, flashing lights for school zones and some police equipment.

Last Thursday, after Trump unveiled his proposed budget for fiscal year 2018, ASCE president Norma Jean Mattei issued a discouraging note, writing that the president's budget «would eliminate funding for many of the programs designed to improve our nation's infrastructure.»

DuPont early this year announced a $ 4 billion buyback program — on top of a $ 5 billion program announced a year earlier — to beat back activist investor Nelson Peltz's Trian Fund Management, which was seeking four board seats to get its way.

Funded by Global Affairs Canada and managed by the Asia Pacific Foundation of Canada and the APEC Secretariat, the program is now nearing the end of its first year, with a focus on Vietnam.

Rockwell Collins» Green Communities program passes $ 1 million mark in total donations - Apr 19, 2018 - Rockwell Collins has announced the recipients of this year's Green Communities grants, a program that helps fund environmental projects in communities that Rockwell Collins operates in.